METARAMINOL BITARTRATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for metaraminol bitartrate and what is the scope of freedom to operate?

Metaraminol bitartrate is the generic ingredient in two branded drugs marketed by Merck, Abraxis Pharm, Elkins Sinn, Fresenius Kabi Usa, Gd Searle Llc, and Slayback Pharma Llc, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Merck	ARAMINE	metaraminol bitartrate	INJECTABLE;INJECTION	009509-002	Dec 22, 1987		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Slayback Pharma Llc	METARAMINOL BITARTRATE	metaraminol bitartrate	INJECTABLE;INJECTION	211304-001	Aug 24, 2021		RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Gd Searle Llc	METARAMINOL BITARTRATE	metaraminol bitartrate	INJECTABLE;INJECTION	086418-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Abraxis Pharm	METARAMINOL BITARTRATE	metaraminol bitartrate	INJECTABLE;INJECTION	080431-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Fresenius Kabi Usa	METARAMINOL BITARTRATE	metaraminol bitartrate	INJECTABLE;INJECTION	080722-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	2
Applicants:	6
NDAs:	6
Raw Ingredient (Bulk) Api Vendors:	82
Patent Applications:	627
DailyMed Link:	METARAMINOL BITARTRATE at DailyMed